|
TTPAL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09810000040278E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.47859996363553E-09 |
| Normal-vs-Stage2 |
5.78930000050271E-07 |
| Normal-vs-Stage3 |
1.249550E-04 |
| Normal-vs-Stage4 |
2.915100E-03 |
| Stage1-vs-Stage2 |
6.688000E-01 |
| Stage1-vs-Stage3 |
3.888200E-01 |
| Stage1-vs-Stage4 |
1.369240E-01 |
| Stage2-vs-Stage3 |
2.942200E-01 |
| Stage2-vs-Stage4 |
1.158590E-01 |
| Stage3-vs-Stage4 |
5.641400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92360000039749E-07 |
| Normal-vs-AfricanAmerican |
2.552200E-04 |
| Normal-vs-Asian |
2.668400E-01 |
| Caucasian-vs-AfricanAmerican |
9.570800E-01 |
| Caucasian-vs-Asian |
4.056400E-01 |
| AfricanAmerican-vs-Asian |
4.607600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04270000025986E-07 |
| Normal-vs-Female |
8.95350005247764E-09 |
| Male-vs-Female |
5.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.642900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.73639999548436E-08 |
| Normal-vs-Age(61-80Yrs) |
7.15889999947095E-07 |
| Normal-vs-Age(81-100Yrs) |
4.502400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.322200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.205200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.982800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.160800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.681800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.917600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.218900E-03 |
| Normal-vs-Grade 2 |
5.35550004343577E-09 |
| Normal-vs-Grade 3 |
6.03830000001082E-07 |
| Normal-vs-Grade 4 |
1.365390E-01 |
| Grade 1-vs-Grade 2 |
9.285600E-01 |
| Grade 1-vs-Grade 3 |
7.576200E-01 |
| Grade 1-vs-Grade 4 |
1.552830E-01 |
| Grade 2-vs-Grade 3 |
2.545200E-01 |
| Grade 2-vs-Grade 4 |
1.198170E-03 |
| Grade 3-vs-Grade 4 |
1.096060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.08526554199307E-12 |
| Normal-vs-ccB subtype |
3.459200E-03 |
| ccA subtype-vs-ccB subtype |
1.95243999999706E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.0032000004373E-07 |
| Normal-vs-N1 |
7.767000E-01 |
| N0-vs-N1 |
7.386400E-02 |
|
|
